Clinical trials
Venous Thromboembolism trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 3 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Terminated | 7 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 13 |
| Boehringer Ingelheim | 5 |
| Daiichi Sankyo | 4 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 3 |
| Leiden University Medical Center | 3 |
| Anthos Therapeutics, Inc. | 2 |
| Sanofi | 2 |
| University of Calgary | 2 |
| Utrecht Institute for Pharmaceutical Sciences | 2 |
| Boston Scientific Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Venous Thromboembolism | 49 |
| Venous Thrombosis | 18 |
| Pulmonary Embolism | 16 |
| Neoplasms | 6 |
| Thromboembolism | 5 |
| Thrombosis | 4 |
| Atrial Fibrillation | 3 |
| Cardiovascular Diseases | 2 |
| Embolism and Thrombosis | 2 |
| Hemorrhage | 2 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.